(Press-News.org) Contact information: Marie-Helene Thibeault
m.thibeault@ucalgary.ca
403-679-8447
University of Calgary
Bacterium infecting cystic fibrosis patients genetically evolves to live in lungs and evade antibiotic treatments
Research by University of Ottawa and University of Calgary scientists opens the door to more effective treatments for life-threatening disease
The bacterium that's the most important pathogen in patients with cystic fibrosis (CF) has genetically evolved and adapted to survive in CF-infected lungs and evade antibiotic treatments, scientists from the University of Ottawa and the University of Calgary have shown.
Pseudomonas aeruginosa is called an "opportunistic pathogen." While the microorganism is widespread in the environment and is harmless to healthy people, it infects those who are ill or have compromised immune systems.
The team of scientists performed the first systematic analysis of entire genomes (the full genetic 'blueprint') for multiple "epidemic and nonepidemic" strains of P. aeruginosa.
Their analysis showed that the main drivers for the evolution and adaptation of the bacterium are the CF-lung environment itself and the presence of antibiotics.
"Many of the genes and pathways implicated in adaptive evolution within the host had obvious roles in the pathogenic lifestyle of this bacteria," says their study, published this week in the Proceedings of the National Academic of Sciences of the United States of America.
Lead author is Jeremy R. Dettman, from the Centre for Advanced Research in Environmental Genomics at the University of Ottawa.
Better understanding of how the pathogen evolves will help advance more effective treatments for infected cystic fibrosis patients, says co-author Nicolas Rodrigue, University of Calgary professor of statistics in the Department of Mathematics and Statistics in the Faculty of Science.
"If we can devise a multi-pronged treatment approach that addresses all or most of the different ways that the bacteria can adapt to different treatments, then the bacteria will be out of luck," Rodrigue says.
Approximately 4,000 people have cystic fibrosis in Canada, and one person in the country dies from the disease each week, according to Cystic Fibrosis Canada.
The unique aspect of the new study is that "we looked at a large number of strains. Instead of looking at just a few genes here and there, we looked at the entire genomes of all these 32 strains," Rodrigue says.
The scientists also found that an epidemic strain of P. aeruginosa has spread between clinics in the United Kingdom and North America – likely through international air travel.
As a statistician, Rodrigue's key role was to devise and implement the computational and statistical approaches used to analyze a massive amount of data.
He used computer programs – including some he wrote himself – to assemble "millions of little snippets" of DNA into the genomes for each bacterial strain. "It's like a huge jigsaw puzzle that we have to put together," he says.
Rodrigue also performed a "statistical inference of the evolutionary relationships" among all 32 strains. This included identifying which genes had been gained or lost during evolution, which underwent genetic recombination and which were the target of selection.
Rodrigue, who joined the University of Calgary in September, says a multidisciplinary research approach increasingly will be needed given the growing richness of scientific data. "Statisticians will have to know a lot about the science in which they're working. And the scientists are going to have to become more statistically sophisticated and knowledgeable."
INFORMATION:
The study received financial support from the Natural Sciences and Engineering Research Council of Canada and the Canadian Institutes of Health Research.
Bacterium infecting cystic fibrosis patients genetically evolves to live in lungs and evade antibiotic treatments
Research by University of Ottawa and University of Calgary scientists opens the door to more effective treatments for life-threatening disease
2013-12-12
ELSE PRESS RELEASES FROM THIS DATE:
Breast cancer treatment selection is improved by genomic tests at Jefferson Breast Care Center
2013-12-12
Breast cancer treatment selection is improved by genomic tests at Jefferson Breast Care Center
Molecular subtyping enables more accurate prognosis and treatment selection, according to research presented at San Antonio conference
...
Neuroscience method of optogenetics as good as electrical stimulation
2013-12-12
Neuroscience method of optogenetics as good as electrical stimulation
PROVIDENCE, R.I. [Brown University] — Neuroscientists are eagerly, but not always successfully, looking for proof that optogenetics – a celebrated technique that uses pulses of visible light ...
PIK3CA gene mutations make HER2- and hormone receptor-positive breast cancers treatment-resistant
2013-12-12
PIK3CA gene mutations make HER2- and hormone receptor-positive breast cancers treatment-resistant
SAN ANTONIO — Women with breast cancer characterized by high levels of the protein HER2 and hormone receptors gained much less benefit from presurgery ...
Exercise improves drug-associated joint pain in breast cancer survivors
2013-12-12
Exercise improves drug-associated joint pain in breast cancer survivors
SAN ANTONIO — Breast cancer survivors taking aromatase inhibitors (AIs) such as anastrozole, letrozole, and exemestane experienced a reduction in joint pain if they exercised ...
New drug combination delayed disease progression for subgroup of women with metastatic breast cancer
2013-12-12
New drug combination delayed disease progression for subgroup of women with metastatic breast cancer
SAN ANTONIO — Adding the drug dasatinib to a standard antihormone therapy, letrozole, doubled the time before disease progressed for women with ...
Antihormone therapy anastrozole may provide new option for breast cancer prevention
2013-12-12
Antihormone therapy anastrozole may provide new option for breast cancer prevention
SAN ANTONIO — Breast cancer incidence among postmenopausal women at high risk for developing the disease was significantly reduced by the antihormone therapy ...
Combining mutants results in 5-fold lifespan extension in C. elegans
2013-12-12
Combining mutants results in 5-fold lifespan extension in C. elegans
Research highlights possibility of combination therapy for aging
What are the limits to longevity? New research in simple animals suggests that combining mutants can lead to radical ...
Temple scientists studying mitochondrial calcium handling yield new disease targets
2013-12-12
Temple scientists studying mitochondrial calcium handling yield new disease targets
(Philadelphia, PA) – When things go wrong, cells turn to built-in safety mechanisms for survival. One of those mechanisms involves calcium uptake by mitochondria, ...
Partially blocking blood vessels' energy source may stop cancer growth, blindness & other conditions
2013-12-12
Partially blocking blood vessels' energy source may stop cancer growth, blindness & other conditions
VIDEO:
This is a confocal time-lapse video imaging of a control (A; DMSO) ...
Surprise: Duck-billed dinosaurs had fleshy 'cocks comb'
2013-12-12
Surprise: Duck-billed dinosaurs had fleshy 'cocks comb'
A rare, mummified specimen of the duck-billed dinosaur Edmontosauraus regalis described in the Cell Press journal Current Biology on December 12 shows for the first time that those dinosaurs' heads were adorned with a ...
LAST 30 PRESS RELEASES:
Hallucinogen use linked to 2.6-fold increase in risk of death for people needing emergency care
Pathogenicity threshold of SCA6 causative gene CACNA1A was identified
Mysterious interstellar icy objects
Chronic diseases misdiagnosed as psychosomatic can lead to long term damage to physical and mental wellbeing, study finds
Omalizumab treats multi-food allergy better than oral immunotherapy
Sleep apnea linked to increased risk of Parkinson’s, but CPAP may reduce risk
New insights into drug addiction: The role of astrocytic G protein-coupled receptors
Digital twin technology: Transforming road engineering and its lifecycle applications
Next-generation AI and big data: Transforming crop breeding
Biomimetic synthesis of natural products: Progress, challenges and prospects
New limits found for dark matter properties from latest search
SCAI expresses disappointment over ABMS decision to deny independent cardiovascular medicine boar
Rice researchers develop efficient lithium extraction method, setting stage for sustainable EV battery supply chains
Statement on ABMS denying new cardiovascular board
St. Jude scientists solve mystery of how the drug retinoic acid works to treat neuroblastoma
New device could allow you to taste a cake in virtual reality
Illinois researchers develop next-generation organic nanozymes and point-of-use system for food and agricultural uses
Kicking yourself: Going against one’s better judgment amplifies self-blame
Rice researchers harness gravity to create low-cost device for rapid cell analysis
Revolutionary copper-infused microvesicles: a new era in biofunctional medicine
Primary care practices with NPs are key to increasing health care access in less advantaged areas, Columbia Nursing study shows
TTUHSC conducting study to help patients that experience traumatic blood loss
Next top model: Competition-based AI study aims to lower data center costs
Innovative startup awarded $10,000 to tackle cardiovascular disparities
Study compares indoor transmission-risk metrics for infectious diseases
Micro-expression detection in ASD movies: a YOLOv8-SMART approach
Machine learning on blockchain: A new approach to engineering computational security
Vacuum glazing: A promising solution for low-carbon buildings
Racial and ethnic differences in out-of-pocket spending for maternity care
Study reveals racial and ethnic disparities in maternity care spending
[Press-News.org] Bacterium infecting cystic fibrosis patients genetically evolves to live in lungs and evade antibiotic treatmentsResearch by University of Ottawa and University of Calgary scientists opens the door to more effective treatments for life-threatening disease